Edition:
United Kingdom

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

18.04USD
12 Dec 2017
Change (% chg)

$0.14 (+0.78%)
Prev Close
$17.90
Open
$17.77
Day's High
$18.69
Day's Low
$17.69
Volume
74,506
Avg. Vol
53,922
52-wk High
$26.74
52-wk Low
$13.54

Select another date:

Tue, Nov 7 2017

BRIEF-Kala Pharmaceuticals reports Q3 loss per share $0.56

* Kala Pharmaceuticals reports third quarter 2017 financial results and provides business update

BRIEF-Kala Pharmaceuticals submits new drug application for Inveltystm

* Kala pharmaceuticals submits new drug application to U.S. Food and Drug Administration for Inveltystm (KPI-121 1 pct) Source text for Eikon: Further company coverage:

BRIEF-Wellington Management Group reports 11.84 pct passive stake in Kala Pharmaceuticals - SEC filing‍​

* Wellington Management Group LLP reports 11.84 percent passive stake in Kala Pharmaceuticals Inc as of July 31, 2017 - SEC filing‍​ Source text: (http://bit.ly/2wxa3C9) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

BRIEF-Hadley Harbor Master Investors (Cayman) L.P. reports 7.45 pct passive stake in Kala Pharmaceuticals Inc

* Hadley Harbor Master Investors (Cayman) L.P. reports 7.45 percent passive stake in Kala Pharmaceuticals Inc as on July 20, 2017 - Sec Filing‍​ Source text (http://bit.ly/2uNGNIC) Further company coverage:

BRIEF-Kala Pharma announces pricing of initial public offering

* Kala Pharmaceuticals announces pricing of initial public offering

BRIEF-Kala Pharma sees IPO of 6 mln shares priced between $14-$16/shr

* Kala Pharmaceuticals sees IPO of 6 million shares of co's common stock priced between $14.00 and $16.00 per share Source text: (http://bit.ly/2tFlt5R) Further company coverage:

Select another date: